 Standard treatment for non-small cell lung cancer NSCLC involves a combined therapy of paclitaxel and carboplatin. These drugs are administered once every 21 days. This study adds high dose ascorbic acid 75g per infusion twice per week for up to 4 cycles of therapy. 